Atlas Venture

Sobre

Atlas Venture creates and finances breakthrough biotechnology companies, working alongside scientific founders and experienced operators from company formation through clinical development. The firm commonly leads company formation, Seed and Series A financings and raised $450M for Fund XIV in 2026.

Sectores

• Ciencias de la vida

Inversiones destacadas

• Alnylam Pharmaceuticals
• Exelixis
• Intellia Therapeutics
• Kymera Therapeutics
• Dyne Therapeutics
• Disc Medicine
• Replimune
• Cogent Biosciences

Inversores

• Aimee RaleighPrincipal→
• Bruce BoothPartner→
• David GrayzelPartner→
• Jason RhodesPartner→
• Jean-Francois FormelaPartner→
• Jernej GodecPrincipal→
• Julia PianSenior Associate→
• Justin FengSenior Associate→
• Kevin BittermanPartner→
• Maurizio FazioPrincipal→
• Michael GladstonePartner→
• Stella PaffenholzSenior Associate→

Cómo contactarlos

lifesciences@atlasventure.com